While Express Scripts (ESRX) took a bit of a fall after its disappointing outlook last quarter, in the following video Motley Fool health care bureau chief Brenton Flynn reminds us that the best way to invest is to understand the core of a business in the long run, rather than focusing on short-term news. He shares some key takeaways from the company's presentation at the JPMorgan conference this week, beyond the typical "generic utilization" metric often cited as a boost to PBMs, to give us some of the things Express Scripts sees as real growth drivers for it for the long run.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
How This PBM Plans to Win
NASDAQ: ESRX
Express Scripts Holding Company

Express Scripts' future plans for growth.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Express Scripts. The Motley Fool owns shares of Express Scripts. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned




*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.